SUNRISE, FL / ACCESSWIRE / September 1, 2022 / U.S. Stem Cell, Inc. OTC:USRM, a leader in the development of proprietary, physicianbased stem cell therapies and novel regenerative medicine solutions, is pleased to announce the longawaited favorable ruling of the contemporaneous stem cell case against Cell Surgical Network, a stem cell company involved in a similar stem procedure as U.S. Stem Cell... Lire le communiqué |